Biotree

BiotechnologySeries AShanghai, Chinabiotree.cn

Latest round

Series A

Last raised

Jan 2023

Total raised

$15M

Investors

3

About Biotree

Based in Shanghai, China and established in 2012, Biotree is a biology technology company that engages in the R&D of metabolomics and proteomics. The company cooperated with over 1500 universities, R&D institutions, hospitals, and pharmaceutical enterprises. The company provides testing and analysis services in life science, including R&D services, pharmaceutical enterprise services, clinical mass spectrometry services, and big data informatization service platform. The company's genomics service can be used for disease early screening and diagnosis products. The company has multiple testing analysis platforms, including non-targeted metabolomics, high-throughput targeted metabolomics, lipidomics, metabolic flow, proteomics, and antibody sequencing.

Who invested in Biotree

3 investors across 2 rounds

See all investors in Biotree

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 3, 2023

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Jul 15, 2022

    Amount

    $15M

    Investors

    Locked

Questions about Biotree

Who invested in Biotree?

Biotree has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Biotree raised?

Biotree has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Biotree last raise money?

Biotree's most recent round on record is a Series A, in Jan 2023.

What does Biotree do?

Based in Shanghai, China and established in 2012, Biotree is a biology technology company that engages in the R&D of metabolomics and proteomics.

Where is Biotree headquartered?

Biotree is headquartered in Shanghai, China.

Which VCs invest in companies like Biotree?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Biotree's stage. Their profiles are linked below.

Raising like Biotree? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.